Evidence map›Paper›PMID 35415036›Full record

ArticleCureus2022

Report of a Case of Creutzfeldt-Jakob Disease With an Unusual Quick Evolution.

Hajar Fadili, Rim Tazi, Hiba El Oury, Karim El Aidaoui, Asmaa Hazim

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Hajar FadiliNeurology, Cheikh Khalifa Bin Zayed Al Nahyan Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR.
Rim TaziNeurology, Cheikh Khalifa Bin Zayed Al Nahyan Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR.
Hiba El OuryNephrology, Cheikh Khalifa Bin Zayed Al Nahyan Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR.
Karim El AidaouiAnesthesia and Critical Care, Cheikh Khalifa Bin Zayed Al Nahyan Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR.
Asmaa HazimNeurology, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR.
Université Mohammed VI des Sciences de la Santé · MAUniversity of Health Science · KHUniversity of Health Sciences

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Creutzfeldt-Jakob disease is a rare, transmissible neurodegenerative disorder, most prevalent between the ages of 50 and 70 years old, that is incurable and fatal. It's caused by a slow, infectious protein agent-designated prion. The most common clinical presentations are sleep disturbances, personality changes, ataxia, aphasia, visual disturbances, weakness, and myoclonus combined with progressive dementia. Here we report the case of a patient with disturbance of consciousness, restlessness, and myoclonia who died two weeks after admission. The analysis of his cerebrospinal fluid reveals that the presence of 14-3-3 protein was positive, which supports the diagnosis of Creutzfeldt-Jakob disease. Our observation underscores the importance of the quick fatality of this case.

Indexed as

14-3-3 proteincreutzfeldt-jakob diseaseencephalopathyneuropathologyprionrapid evolution

Identifiers

PMID35415036
PMCPMC8994046
OpenAlexW4221115244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.